Bringing the fundamentals into focus…
Back to Atara Biotherapeutics, Inc.
How Atara Biotherapeutics, Inc. stacks up
ATRA · against 69 other Healthcare companies of similar size
Growth
58/ 100
Above the middle of the pack.
Ranked #27 of 70 · scores higher than 62% of peers
Bars: peers in each 10-point band of the growth score5 peers with a growth score of 50–59, including ATRA · Click a bar to see the companies
Why growth scores 58?
Weighted metrics compared with all Healthcare companies.A mix: stronger 3-year revenue growth, but weaker revenue growth than most Healthcare peers.
- slower revenue growth over the last year: weaker than 80% of peers. Revenue growth: -6.3% vs peer median 6.1%
- Earnings per share growth is not reported, so it is left out of the score.
- faster revenue growth over three years: stronger than 84% of peers. 3-year revenue growth: 23.9% vs peer median 5.8%
Metric by metric
Position: dot = ATRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ATRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 75 reported | -6.3% | 5.6% | 24% | 33% | |
| Earnings per share growthHigher is better · 20 reported | Not reported | 4.1% | — | — | 33% |
| 3-year revenue growthHigher is better · 72 reported | 23.9% | 2.0% | 82% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ATRA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 90M USD | 99 | 27 | |
| 1 | 649M SEK (≈$65M) | 99 | 29 | |
| 1 | 97M USD | 99 | 63 | |
| 5 | 79M EUR (≈$87M) | 98 | 34 | |
| 23 | 68M EUR (≈$75M) | 67 | 34 | |
| 24 | 3.0B THB (≈$83M) | 66 | 52 | |
| 25 | 93.7B KRW (≈$67M) | 65 | 36 | |
| 26 | 198.9B KRW (≈$143M) | 60 | 61 | |
| 27 | 82M USD | 58 | 27 | |
| 28 | 178.5B KRW (≈$129M) | 55 | 76 | |
| 28 | 139M USD | 55 | 32 | |
| 30 | 1.1B HKD (≈$146M) | 53 | 72 | |
| 30 | 51M EUR (≈$56M) | 53 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score